top of page

Photobiomodulation Evidence

Scientific Evidence Supporting Photobiomodulation

Photobiomodulation (PBM) is supported by a growing body of clinical and experimental research investigating its effects on cellular function, inflammatory processes, pain and tissue repair.

​

This evidence page brings together key mechanisms of action, peer-reviewed clinical studies and real-world clinical applications that underpin the use of PBM across healthcare, rehabilitation and human performance.

Mechanisms of Action

Cellular Energy Production

PBM is thought to interact with mitochondrial chromophores, including cytochrome c oxidase, influencing cellular energy metabolism and ATP production.

Tissue Repair & Regeneration

PBM has been investigated for its effects on cellular activity, collagen synthesis and angiogenesis, mechanisms that may contribute to tissue repair and regeneration.

Inflammation Modulation

PBM has been shown to influence inflammatory signalling pathways and may modulate the production of pro-inflammatory mediators involved in the tissue response to injury.

Pain Reduction

PBM has been investigated for its effects on pain-related signalling pathways, including potential influences on neural activity and inflammatory processes associated with pain.

Featured Clinical Summaries

Effect of Photobiomodulation on Healing of Diabetic Foot Ulcers

Clinical Question

Can photobiomodulation accelerate healing in patients with diabetic foot ulcers?

​

Study

A randomised controlled clinical trial evaluating the effectiveness of photobiomodulation as an adjunct to standard wound care in patients with diabetic foot ulcers. Healing outcomes, wound size and treatment response were compared with standard care alone.

​

Key Findings

  • Faster wound healing compared with standard care alone.

  • Greater reduction in wound size throughout the treatment period.

  • Increased rate of complete wound closure.

  • Treatment was safe, well tolerated and associated with no significant adverse effects.

  • ​

Clinical Relevance

This study demonstrates that photobiomodulation can significantly enhance the healing of diabetic foot ulcers when used alongside standard wound care. By stimulating cellular repair, improving microcirculation and supporting tissue regeneration, PBM represents a valuable adjunctive therapy for one of the most challenging complications of diabetes.

Photobiomodulation Modulates Cellular Function Through Cytochrome c Oxidase Activation

Clinical Question

How does photobiomodulation influence cellular function and promote tissue repair?

​

Study

A comprehensive review of the cellular and molecular mechanisms of photobiomodulation, examining how specific wavelengths of red and near-infrared light interact with mitochondrial chromophores to influence energy production, inflammation and tissue regeneration.

​

Key Findings

  • Red and near-infrared light are absorbed by cytochrome c oxidase within the mitochondria.

  • Photobiomodulation increases ATP production, providing additional cellular energy for repair and regeneration.

  • Light therapy promotes the release of nitric oxide, improving microcirculation and oxygen delivery to tissues.

  • Reactive oxygen species are regulated, activating signalling pathways involved in tissue repair, angiogenesis and inflammation control.

  • ​

Clinical Relevance

Understanding the cellular mechanisms of photobiomodulation provides the scientific foundation for its clinical use. By improving mitochondrial function and supporting normal cellular repair processes, PBM offers a non-invasive approach to enhancing healing, reducing inflammation and optimising recovery across a wide range of clinical conditions.

Photobiomodulation for Tendinopathy

Clinical Question

Can photobiomodulation reduce pain and improve function in patients with tendinopathy?

​

Study

A systematic review and meta-analysis of randomised controlled trials evaluating the effectiveness of red and near-infrared photobiomodulation, used alone or alongside exercise therapy, for the treatment of tendinopathy. 

​

Key Findings

  • Significant pain reduction when PBM was combined with exercise therapy.

  • Improved patient-reported functional outcomes compared with sham treatment plus exercise.

  • PBM was most effective as an adjunct to a structured rehabilitation programme rather than a standalone treatment.

  • Treatment was safe and well tolerated, with very few reported adverse effects. 

​

Clinical Relevance

This review supports photobiomodulation as an effective adjunct to evidence-based rehabilitation for tendinopathy. When integrated with progressive loading and exercise therapy, PBM may reduce pain, enhance functional recovery and support an earlier return to activity.

Photobiomodulation for Chronic Musculoskeletal Pain

Clinical Question

Can photobiomodulation reduce pain and improve function in patients with chronic musculoskeletal disorders?

​

Study

A systematic review and meta-analysis evaluating the effectiveness of photobiomodulation in the treatment of chronic musculoskeletal pain across a range of clinical conditions.

​

Key Findings

  • Significant reductions in pain intensity compared with control treatments.

  • Improved physical function and quality of life in many patients.

  • Reduced reliance on analgesic medication in several studies.

  • Treatment was safe, non-invasive and associated with very few adverse effects.

  • ​

Clinical Relevance

This review supports the use of photobiomodulation as an effective adjunctive treatment for chronic musculoskeletal pain. By reducing inflammation, enhancing cellular repair and promoting tissue recovery, PBM offers clinicians a non-invasive option that can be integrated into physiotherapy, rehabilitation and pain management programmes.

Photobiomodulation for Exercise Performance and Recovery

Clinical Question

Can photobiomodulation improve recovery and support a faster return to play following sports-related injury?

​

Study

A systematic review and meta-analysis evaluating the effects of photobiomodulation on pain, recovery and return to play in injured athletes.

​

Key Findings

  • Reduced pain following musculoskeletal injury.

  • Earlier return to sport compared with standard rehabilitation alone.

  • Improved recovery when PBM was incorporated into rehabilitation programmes.

  • Safe, non-invasive treatment with no significant adverse effects reported.

​

Clinical Relevance

This systematic review supports the use of photobiomodulation as an adjunct to sports rehabilitation. By reducing pain and supporting tissue recovery, PBM may help clinicians optimise rehabilitation programmes and facilitate a safe return to training and competition for injured athletes.

Photobiomodulation for Knee Osteoarthritis

Clinical Question

Can photobiomodulation reduce pain and improve function in patients with knee osteoarthritis?

​

Study

A systematic review and meta-analysis of randomised placebo-controlled trials evaluating the effectiveness of photobiomodulation in patients with knee osteoarthritis. 

​

Key Findings

  • Significant reduction in pain compared with placebo.

  • Improvements in physical function and disability scores.

  • Greatest benefit when PBM was used alongside established conservative treatments such as exercise therapy.

  • Safe, non-invasive intervention with very few reported adverse effects. 

​​

Clinical Relevance

This systematic review demonstrates that photobiomodulation can provide meaningful pain relief and improve function in patients with knee osteoarthritis. PBM is best used as part of a comprehensive rehabilitation programme, complementing exercise therapy and other evidence-based conservative treatments rather than replacing them.

Explore Photobiomodulation in Clinical Practice

Explore the evidence supporting photobiomodulation across pain management, tissue repair, rehabilitation and recovery. Whether you're considering PBM for the first time or exploring its role within clinical practice, we're here to help.

ChatGPT Image Jul 24, 2026 at 04_47_57 PM.png

Registered Office:

168 Lee Lane

Horwich

Bolton

BL6 7AF

Registered in England & Wales.

Company No 8092194

VAT No: 2520984081

bottom of page